Literature DB >> 2829171

Hepatitis B virus suppresses expression of human beta-interferon.

J S Twu1, C H Lee, P M Lin, R H Schloemer.   

Abstract

To determine whether hepatitis B virus (HBV) regulates the expression of the human beta-interferon gene, a series of recombinant bovine papilloma virus plasmids containing the human interferon gene and various fragments of the HBV genome were constructed and used to transform C127 cells, a murine fibroblast line. Analysis of the DNA from transformed C127 cells indicated that the interferon gene was intact and that the plasmids replicated as stable multicopy elements. The 1828-base-pair BamHI HBV DNA fragment containing the core antigen gene, but not the 2755-base-pair Bgl II HBV DNA fragment encoding both the surface antigen and the X antigen, suppressed the production of human beta-interferon. No effect by any of the recombinant plasmids on the synthesis of murine interferon was detected. The suppression of human beta-interferon by HBV occurs via a trans-acting factor. A frameshift mutation within the HBV core gene alleviates the inhibitory activity; thus we infer that the core protein is this factor or is crucially associated with this activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829171      PMCID: PMC279522          DOI: 10.1073/pnas.85.1.252

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Studies on the production, mode of action and properties of interferon.

Authors:  J LINDENMANN; D C BURKE; A ISAACS
Journal:  Br J Exp Pathol       Date:  1957-10

2.  Activation of the human beta-interferon gene requires an interferon-inducible factor.

Authors:  T Enoch; K Zinn; T Maniatis
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

3.  The human beta-interferon gene enhancer is under negative control.

Authors:  S Goodbourn; H Burstein; T Maniatis
Journal:  Cell       Date:  1986-05-23       Impact factor: 41.582

4.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

5.  Non-production of interfering substances by serum from patients with infectious hepatitis.

Authors:  P E Taylor; A J Zuckerman
Journal:  J Med Microbiol       Date:  1968-11       Impact factor: 2.472

6.  Lymphocyte transformation and hepatitis. I. Impairment of thymidine incorporation and DNA polymerase activity.

Authors:  S S Agarwal; B S Blumberg; B J Gerstley; W T London; I Millman; A I Sutnick; L A Loeb
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

7.  Absence of circulating interferon in patients with infectious and serum hepatitis.

Authors:  E F Wheelock; S Schenker; B Combes
Journal:  Proc Soc Exp Biol Med       Date:  1968-05

8.  Failure to demonstrate circulating interferon during incubation period and acute stage of transfusion-associated hepatitis.

Authors:  D A Hill; J H Walsh; R H Purcell
Journal:  Proc Soc Exp Biol Med       Date:  1971-03

9.  Development of macrophages in phytohaemagglutinin cultures of blood from patients with idiopathic steatorrhoea and with cirrhosis.

Authors:  G C Winter; C F McCarthy; A E Read; J M Yoffey
Journal:  Br J Exp Pathol       Date:  1967-02

10.  Transcriptional control elements of hepatitis B surface antigen gene.

Authors:  A Siddiqui; S Jameel; J Mapoles
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

View more
  16 in total

Review 1.  Mechanisms of immune escape in viral hepatitis.

Authors:  W Rosenberg
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 2.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

3.  Targeting viral dsRNA for antiviral prophylaxis.

Authors:  Zhou Fei; Yang Liu; Zhen Yan; Daiming Fan; Alice Alexander; Jing-Hua Yang
Journal:  FASEB J       Date:  2009-10-30       Impact factor: 5.191

Review 4.  Liver disease.

Authors:  S D Ryder; R Williams
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

5.  Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma.

Authors:  Saravana Kumar Kailasam Mani; Ourania Andrisani
Journal:  Cytokine       Date:  2018-08-17       Impact factor: 3.861

6.  Hepatic expression of interferon-alpha in chronic hepatitis B virus infection.

Authors:  J W Fang; P C Wu; C L Lai; C K Lo; A Meager; J Y Lau
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

7.  Protein composition of the hepatitis B virus e antigen in the natural course of disease and following interferon therapy.

Authors:  M L Campillo; J A Quiroga; J Bartolomé; G Moraleda; I Castillo; V Carreño
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

8.  Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene.

Authors:  T M Whitten; A T Quets; R H Schloemer
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

9.  Reduced production of immunoreactive interleukin-1 by peripheral blood monocytes of patients with acute and chronic viral hepatitis.

Authors:  C Müller; P Knoflach; C C Zielinski
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

Review 10.  Immunology of hepatitis B virus infections.

Authors:  K H Heermann; W H Gerlich
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.